Navigation Links
Researchers develop new tool to eliminate 30-day hospital readmissions in heart failure patients
Date:3/9/2013

SALT LAKE CITY Researchers at the Intermountain Heart Institute at Intermountain Medical Center have developed an innovative tool designed to eliminate 30-day hospital readmissions for heart failure patients and improve the quality of medical care a patient receives in the hospital.

The tool, known as the IMRS-HF, was adapted from the Intermountain Risk Score (IMRS) that has been used at Intermountain Medical Center to predict mortality rates in trauma patients.

Heart researchers discovered that by using the IMRS-HF, they could more accurately evaluate a patient's condition prior to discharge, and ensure there is less risk of the patient being readmitted for the same condition within 30 days.

"The IMRS-HF is another step forward in using evidence-based care to improve the quality of medical care provided to heart failure patients during a hospital stay," said Benjamin Horne, PhD, director of cardiovascular and genetic epidemiology at the Intermountain Heart Institute at Intermountain Medical Center, and lead researcher. "When implemented, this gives physicians an effective, real-time tool to help assure patients are in a healthy position for discharge."

Researchers designed the tool following an extensive examination of more than 6,000 electronic medical records involving discharged heart failure patients from Intermountain Healthcare hospitals between 1999 and 2011.

The IMRS-HF tool was then validated using 459 patients hospitalized between April 2011 and October 2012. Using this new tool, researchers discovered that male patients with a score higher than 15 (on a 1-19 scale) were 8.5 times more likely to be readmitted within 30 days compared to a male patient with a score between one and eight. Women with a score of 5-9 (on a 0-9 scale) were twice as likely to be readmitted than a female patient with a score between 0-3.

Results of the project were presented at the American College of Cardiology's Ann
'/>"/>

Contact: Jess C. Gomez
jess.gomez@imail.org
801-718-8495
Intermountain Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. NIH awards $20 million over 5 years to train next generation of global health researchers
2. Researchers develop a new cell and animal model of inflammatory breast cancer
3. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
4. Researchers Find Gene Mutations That May Be a Key to Autism
5. Researchers find evidence of banned antibiotics in poultry products
6. NJ stroke researchers report advances in spatial neglect research at AAN Conference
7. Autism by the numbers: Yale researchers examine impact of new diagnostic criteria
8. Researchers Map Brain Regions Linked to Intelligence
9. Researchers ID Genes That May Determine Mental Illness
10. Researchers Develop Blood Test for Depression
11. University of Cincinnati researchers win $3.7M grant from US Department of Defense
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... ... July 28, 2015 , ... Women fear developing Alzheimer's disease more than having ... attack, and stroke are treatable, but there is little an individual can do to ... part in a clinical trial, reports the July 2015 Harvard Women's Health Watch ...
(Date:7/28/2015)... ... July 28, 2015 , ... A new study published ... Fibromyalgia, Study Says " sheds light on a possible new treatment option for people ... months of regular HBOT sessions, at least five per week, patients experienced a significant ...
(Date:7/28/2015)... ... ... Most employers have been using multi-tier prescription drug plans for many years, ... increase in the use of 4-tier plans, which typically cover the highest cost drugs, ... expected to continue, according to UBA. , UBA’s survey finds that, since 2009, the ...
(Date:7/28/2015)... ... July 28, 2015 , ... PeopleKeys today announced that their ... the EY Entrepreneur of the Year award. The award recognizes the important strides ... the innovative work they have done in incorporating new technology, processes, and procedures ...
(Date:7/28/2015)... ... July 28, 2015 , ... Maryland Brain & Spine has adopted a new ... more service offerings, updated treatment techniques, and additional state-of-the art online resources for patients. ... invasive surgical treatment of brain and spine conditions. , “Adding the word ‘pain’ ...
Breaking Medicine News(10 mins):Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 2Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 3Health News:Recovery Specialists Discuss How Oxygen Therapy Can Ease Fibromyalgia 2Health News:Recovery Specialists Discuss How Oxygen Therapy Can Ease Fibromyalgia 3Health News:Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise 2Health News:Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise 3Health News:Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise 4Health News:Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise 5Health News:Receiving Recognition for Compassionate Care and Innovative Processes: Celtic Healthcare CEO Arnie Burchianti Wins Regional EY Entrepreneur of the Year Award 2Health News:Receiving Recognition for Compassionate Care and Innovative Processes: Celtic Healthcare CEO Arnie Burchianti Wins Regional EY Entrepreneur of the Year Award 3Health News:Maryland Brain & Spine Announces New Specialty, New Name 2Health News:Maryland Brain & Spine Announces New Specialty, New Name 3Health News:Maryland Brain & Spine Announces New Specialty, New Name 4
... of anabolic steroids, more specifically anabolic androgen steroid (AAS) ... sebaceous glands. Sebaceous glands present in the skin // ... of the body surface. ,Anabolic steroids are ... to treat unwanted weight loss in patients with HIV. ...
... Teleradiology can soon offer a solution to the silent ... more than a good night’s sleep. // It ... subjected to middle of the night CT scans or ... emergency department. Such examinations have no doubt yielded the ...
... been raised against the use of Teflon. The Environmental Protection ... to make the substance nonsticky is a possible source of ... cookware was heated to more than 600 degrees Fahrenheit then ... ,Teflon was accidentally discovered in 1938. The Frenchman was ...
... A new law has come into existence to protect the ... McManis, J.D., IP and technology law expert, Thomas and Karole ... has come with various ideas. // This is mainly done ... promote the interest of the local communities. ...
... Sussman, Ph.D., professor anthropology in Arts & Sciences at Washington ... conditions, humans were actually peace loving race in earlier times. ... "Early Humans on the Menu," during the American Association for ... on February 18. ,In his new ...
... children that are raised in Foster homes better off ... children from the orphanages don’t grow to their full ... not irreversible - when the same children were put ... areas. ,Romania’s experiment of Foster homes, that included ...
Cached Medicine News:Health News:International Teleradiology: The Future Of Radiologic Diagnosis 2Health News:Early Man Was A Prey Rather Than A Predator 2
(Date:7/28/2015)... July 28, 2015 According to a ... Type (Device, Formulation), Therapeutic (Hormonal, Oncology), Usage Pattern (Curative Care, ... - Forecast to 2020", published by MarketsandMarkets, the European Injectable ... 2020 from $114.7 Billion in 2015, growing at a CAGR ... 230 market data T ables ...
(Date:7/27/2015)... and WESTLAKE VILLAGE, Calif. , July ... ) and KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH ) ... has granted early termination of the waiting period under ... with respect to Allergan,s pending acquisition of KYTHERA.  ... On July 6, 2015, each of Allergan and KYTHERA ...
(Date:7/27/2015)... , July 27, 2015  SeraCare Life ... diagnostics manufacturers, announced at the 2015 AACC Annual ... partnership agreement with ViveBio, LLC, a biotechnology company ... upon ViveST™ technology.  Products enabled with ViveST™ allow ... shelf stable format.  Under the terms of the ...
Breaking Medicine Technology:European Injectable Drug Delivery Market Worth $207.3 Billion by 2020 2European Injectable Drug Delivery Market Worth $207.3 Billion by 2020 3European Injectable Drug Delivery Market Worth $207.3 Billion by 2020 4Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 2Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 3Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 4Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 5Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 6Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 7Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 8Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 9SeraCare Life Sciences Announces Strategic Partnership with ViveBio to Enable Next Generation Preanalytic Products for the IVD Industry 2SeraCare Life Sciences Announces Strategic Partnership with ViveBio to Enable Next Generation Preanalytic Products for the IVD Industry 3
... Clinic has,clarified the methods of diagnosis and optimal ... of the brain and spinal cord that,often leads ... vasculitis,(PCNSV) can best be identified through a combination ... arteries), brain,biopsy and other laboratory studies., This ...
... at the World Muscle Society International Congress, ... PTC Therapeutics, Inc.,(PTC), a biopharmaceutical company focused ... drugs targeting,post-transcriptional control mechanisms, today announced additional ... PTC124 in patients with Duchenne muscular,dystrophy (DMD) ...
Cached Medicine Technology:Mayo Clinic Clarifies Diagnosis and Treatment for Rare, Serious Blood Vessel Disease of Brain and Spinal Cord 2Mayo Clinic Clarifies Diagnosis and Treatment for Rare, Serious Blood Vessel Disease of Brain and Spinal Cord 3PTC Therapeutics Announces Additional Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 2PTC Therapeutics Announces Additional Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 3PTC Therapeutics Announces Additional Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 4
... These precision 4mL PYREX volumetric ... "To Contain" (TC - bottom ... - top line) to specifications ... Pipets are color-coded with colored ...
... Finnpipette Focus from Thermo Labsystems ... ergonomics with uncompromising performance. ... offers a custom fit for ... shorter tip cones allow easier ...
Inquire...
... A fixed pipette is ... a single volume. Fixed volume ... and advantages as other Finnpipette ... design, Super blow-out (1-40ul), Soft-touch ...
Medicine Products: